Linguistic Validation of Arabic COA and PRO Instruments
A patient-reported outcome instrument only measures what the patient understands. If an Arabic item reads differently in Riyadh and in Cairo, or if the response scale sounds odd to a 70-year-old with heart failure, the data drifts without anyone noticing. Lingoarabia runs the full linguistic validation sequence for clinical outcome assessments going into Arabic, with a pharmacist-led team that has translated and back-translated eCOA and PRO instruments, questionnaires and screeners for 17+ years.
The validation sequence we follow
We work to the standard ISPOR-style methodology that instrument developers and sponsors expect, and we adapt the steps to your protocol and the developer’s own requirements.
- Concept elaboration and translatability review of the source instrument, with queries raised before translation starts.
- Dual forward translation by two independent Arabic medical linguists.
- Reconciliation into a single Arabic version, with a rationale for each decision recorded.
- Back-translation into English by a linguist who has not seen the source.
- Back-translation review and developer review, with every discrepancy resolved and documented.
- Cognitive debriefing interviews with patients from the target population in Egypt or the Gulf.
- Final review, proofreading and the validation report, with the item-by-item history attached.
Each step produces a dated deliverable. The final report gives your regulatory and data teams the audit trail they need, from the first forward translation to the signed-off instrument.
One Arabic, many countries
Arabic is written the same way from Morocco to Oman, but spoken very differently. A validated instrument has to read naturally to patients across that range without sliding into one country’s dialect. Our approach is Modern Standard Arabic at a plain reading level, tested against patients in the countries where your sites are. Where a sponsor needs a country-specific version, such as Arabic for Saudi Arabia or Arabic for Egypt, we harmonise from a shared master so that the versions differ only where they must.
The team has produced Saudi, Egyptian, UAE and pan-Arabic variants of patient-facing material, including a master questionnaire for the UAE of 11,000 words (2019) and paediatric consent material for ages 6 to 11 (2022).
Cognitive debriefing in Egypt and the Gulf
We recruit interview participants who match the protocol’s population and conduct the debriefing in person or by video call, in the participant’s own Arabic. Interviews are run from a structured guide, probing comprehension, relevance and the fit of the response options. Findings go back into the instrument through a documented change log, and the report records what was changed, what was kept, and why.
Instruments and formats
- Patient-reported outcomes (PROs), clinician-reported outcomes (ClinROs) and observer-reported outcomes (ObsROs)
- Quality-of-life questionnaires, symptom diaries, screeners and global impression scales
- eCOA and ePRO builds, including screenshot review on the device or in the vendor’s preview tool
- Paper diaries, patient cards and instruction sheets that travel with the instrument
- Paediatric and adolescent versions with age-appropriate wording
Screenshot review matters more than it looks. Arabic text in an eCOA build can break at line ends, lose its right-to-left order in mixed Arabic-Latin strings, or display numerals in the wrong direction. We check the rendered screens, not only the exported text.
Who does the work
Dr. Ola Siam, B.Pharm., leads the linguistic side and reviews every instrument. The pharmacy background is practical here: a scale about dyspnoea or glycaemic control is translated by someone who understands the clinical concept, not only the words. Second linguists are qualified Arabic medical translators, and back-translators work blind to the source.
Timelines and capacity
A single-instrument validation with cognitive debriefing typically runs several weeks, driven mostly by recruitment and developer review cycles rather than translation time. Senior linguists translate 4,000 to 5,000 words a day and review 7,000, so the linguistic steps are rarely the bottleneck. We give you a step-by-step schedule at the start and report progress against it.
Request a quote
Send the instrument name, the target countries and your study timeline to request a quote. If the developer has a required process, send that too and we will quote to it.
Frequently asked questions
We follow the ISPOR-style sequence that instrument developers expect: translatability review, dual forward translation, reconciliation, back-translation, developer review, cognitive debriefing and a final report. Where the developer or your sponsor has a specific process, we quote to that.
Usually, yes. We write in plain Modern Standard Arabic and test it with patients in the countries where your sites are. When a sponsor requires country-specific versions, we harmonise them from a shared master so the differences are deliberate and documented.
Yes. We recruit participants matching the protocol population in Egypt or the Gulf, interview them in person or by video call using a structured guide, and feed the findings back into the instrument with a documented change log.
We review the rendered Arabic screens on the device or in the vendor’s preview tool. Line breaks, right-to-left order in mixed strings and numeral direction are checked on the screen, because exported text does not show those faults.
The item-by-item history from forward translation to final version, reconciliation rationale, back-translation review notes, debriefing findings and the changes made. It is written so your regulatory and data management teams can file it without rework.
Yes. The team has translated paediatric consent and patient material, including a version for ages 6 to 11 in 2022, and adapts wording and debriefing methods to the age group in the protocol.